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Comparison of DNA Pyrosequencing with Alternative Methods for
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Identification of mycobacterial clinical isolates by pyrosequencing within the hypervariable A region of the
16S rRNA gene was compared to other identification methods. For >90% of isolates, these identifications
correlated to the level of complex or species. For identification of many mycobacteria, pyrosequencing offers an
inexpensive alternative to traditional sequencing.
The number of clinically relevant species of nontuberculous
mycobacteria is increasing steadily (3, 9). In addition to classic
culture-based methods, identification techniques include my-
colic acid analysis (gas-liquid chromatography, thin-layer chro-
matography, and high-performance liquid chromatography
[HPLC]) and molecular methods such as genetic probes or
sequencing of selected regions of the genome. 16S rRNA gene
sequencing is widely used for speciation (2, 5). Restriction
fragment length polymorphism (RFLP) analysis, particularly
of the hsp65 gene, may also be used (8).
In pyrosequencing, sequencing is performed by DNA syn-
thesis. An enzyme cascade that produces visible light detects
the pyrophosphate released during the reaction (7). Resulting
sequences of approximately 30 bases are then compared to
public or private databases. For this study, isolates were iden-
tified by the pyrosequencing of a region within the hypervari-
able A region of the 16S rRNA gene (10). DNA was extracted
from isolates by use of the UltraClean microbial DNA kit (Mo
Bio Laboratories, Carlsbad, CA) per the manufacturer’s in-
structions. PCR amplification was performed as previously de-
scribed (10) with the substitution of Sensimix PCR reagents
(Bioline, Randolph, MA). Pyrosequencing was performed us-
ing Pyro Gold reagents on a Pyromark vacuum prep worksta-
tion and a Pyromark ID instrument per the manufacturer’s
instructions (Biotage, Uppsala, Sweden). Acceptable se-
quences were compared to NCBI GenBank sequences by use
of BLAST analysis (1) and to Ribosomal Database Project
(RDP II) sequences by use of the sequence match tool (4).
Only 100% matches were considered. Species names not in-
cluded in the DMSZ bacterial nomenclature up-to-date data-
base (http://www.dsmz.de) were excluded. Species not known
to be clinically relevant were also excluded. The most likely
identification was considered for comparisons.
Deindentified clinical isolates were acquired as residual pa-
thology samples used in institutional review board-approved
protocols from Tampa General and Sacred Heart Hospitals.
By use of ATCC and clinical isolates, the identifications ob-
tained by pyrosequencing were compared to State of Florida
Department of Health (DOH) or HPLC identification. Nine of
10 ATCC (Manassas, VA) isolates tested, including Mycobac-
terium fortuitum (ATCC 6841), Mycobacterium intracellulare
(ATCC 13950), Mycobacterium marinum (ATCC 927), Myco-
bacterium avium (ATCC 25291), Mycobacterium chelonae
(ATCC 19235, 14472, and 35752), M. tuberculosis (ATCC
27294), and Mycobacterium abscessus (ATCC 19977), were
identified correctly to the species or complex level by 16S
rRNA gene pyrosequencing. However, using pyrosequencing,
multiple identifications were possible with Mycobacterium
kansasii (ATCC 12478).
The DOH performs PCR-RFLP analysis of the hsp65 gene,
DNA probes for the identification of M. tuberculosis complex,
M. avium complex, M. kansasii, and Mycobacterium gordonae,
or HPLC to identify isolates (www.doh.state.fl.us). For 144 of
154 (93.5%) clinical isolates, pyrosequencing and DOH iden-
tifications correlated to the level of complex or species (Table
1). As discussed in the work of Tuohy et al. (10), M. gordonae
isolates consistently produced sequences as short as 16 bases
with pyrosequencing. However, these shorter sequences were
sufficient for species-level identification. Additionally, the spe-
cies M. kansasii, M. simiae, Mycobacterium parascrofulaceum,
and Mycobacterium scrofulaceum were indistinguishable by
pyrosequencing. Samples of these four species were subjected
to pyrosequencing with the forward primer as suggested (10).
Although this additional sequence information also resulted in
multiple possible identifications, the final identification could
sometimes be determined by process of elimination. For ex-
ample, for the single M. simiae isolate tested, BLAST analysis
with the sequencing primer resulted in six possible species
identifications. With the forward primer, 12 identifications
were possible. Only M. simiae was common to both groups.
However, for the single M. scrofulaceum isolate and for two M.
kansasii isolates, an identification of M. parascrofulaceum was
also possible. Therefore, an alternative method such as tradi-
tional sequencing should be considered as a reflex test for
these four species.
Traditional sequencing was used to characterize discordants
and strains with multiple possible identifications (Table 2).
PCR amplification and traditional sequence analysis were per-
formed per the manufacturer’s instructions (Microseq 500 16S
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rRNA gene bacterial identification kit; Applied Biosystems,
Foster City, CA) and electrophoresis was done with an ABI
3130 genetic analyzer. Sequences were compared to GenBank
sequences as previously described and to RIDOM Project da-
tabase sequences (6). An isolate identified as M. gordonae by
the DOH was identified as Mycobacterium xenopi or Mycobac-
terium heckeshornense by pyrosequencing (Table 2). The iso-
late was categorized as M. heckeshornense by traditional 16S
rRNA gene sequencing. A second M. gordonae isolate was
identified as M. interjectum by pyrosequencing. Attempts at
traditional sequencing were unsuccessful, indicating that the
DNA may have been of low quality. Sequencing of isolates
identified as M. avium-M. intracellulare complex and M. inter-
jectum resulted in several possible identifications. Isolates 3
and 13 may have been mixed during processing; these isolates
remain discordant.
Pyrosequencing was also compared to HPLC identification
performed using the MIDI Sherlock identification system
(Newark, DE) using the Agilent 1200 LC system with Chem-
station Base software (Agilent Technologies, Santa Clara, CA)
per the manufacturer’s instructions. Nineteen isolates were
repeated from the comparison above. This group did not in-
clude any discordant isolates. For 69 of 71 (97%) clinical iso-
lates, the identifications correlated to the level of complex or
species (Table 3). One discordant isolate was identified by
HPLC as M. nonchromogenicum and by pyrosequencing as M.
mucogenicum. The DOH determined this isolate to be M.
nonchromogenicum. In this instance, pyrosequencing did not
appropriately identify the isolate. A second isolate was identi-
fied as M. fortuitum by HPLC, M. kansasii by pyrosequencing,
and M. scrofulaceum by the DOH. This isolate most likely
belongs to the group discussed above that is not completely
identified by pyrosequencing of the 16S hypervariable region.
The techniques compared in this study are described in
(Table 4). The techniques vary in advantages and disadvan-
tages. The only nonmolecular identification method tested,
HPLC for mycolic acid content (MIDI Sherlock mycobacte-
rium identification system), has been FDA cleared for M. tu-
berculosis identification but can be used to identify other spe-
cies. The Accuprobe culture identification test has the benefit
of FDA approval but only for a limited number of species.
TABLE 1. Clinical isolates identified by pyrosequencing correlating









M. avium complex M. avium-M.
intracellulare complex
52
M. fortuitum M. fortuitum complex 13
M. goodii M. goodii 1
M. gordonae M. gordonae 22
M. malmoense M. malmoense 1
M. marinum M. marinum 1
M. mucogenicum M. mucogenicum 1
M. peregrinum M. fortuitum complex 7
M. szulgai M. szulgai 4
M. tuberculosis complex M. tuberculosis complex 21
TABLE 2. Isolates discordant for species or complexa
Isolate DOHidentification
Pyrosequencing identification by: Microsequencing identification
(BLAST/RIDOM)BLAST RDP
ATCC 12478 M. kansasii M. simiae, M. parascrofulaceum, M. kansasii,
M. scrofulaceum, M. gastri, M. fortuitum,
M. conspicuum
M. simiae, M. parascrofulaceum,
M. kansasii, M. scrofulaceum,
M. gastri, M. conspicuum
M. kansasii
3 M. szulgai M. simiae, M. parascrofulaceum, M. kansasii,
M. scrofulaceum, M. gastri, M. fortuitum,
M. conspicuum
M. simiae, M. parascrofulaceum,
M. kansasii, M. scrofulaceum,
M. gastri, M. conspicuum
M. kansasii
13 M. kansasii M. szulgai, M. heidelbergense, M.
intracellulare
M. szulgai M. szulgai
26 M. simiae M. simiae, M. parascrofulaceum, M. kansasii,
M. scrofulaceum, M. gastri, M. fortuitum,
M. conspicuum
M. simiae, M. parascrofulaceum,
M. kansasii, M. scrofulaceum,
M. gastri, M. conspicuum
M. simiae
78 M. gordonae M. interjectum M. interjectum NDb
82 M. scrofulaceum M. simiae, M. parascrofulaceum, M. kansasii,
M. scrofulaceum, M. gastri, M. fortuitum,
M. conspicuum
M. simiae, M. parascrofulaceum,
M. kansasii, M. scrofulaceum,




M. celatum, M. malmoense Mycobacteria sp. 98.86% M. simiae-M. szulgai-
M. interjectum
99 M. gordonae M. xenopi, M. heckeshornense M. xenopi, M. heckeshornense M. heckeshornense
213 M. kansasii M. simiae, M. parascrofulaceum, M. kansasii,
M. scrofulaceum, M. gastri, M. fortuitum,
M. conspicuum
M. simiae, M. parascrofulaceum,
M. kansasii, M. scrofulaceum,
M. gastri, M. conspicuum
M. kansasii
227 M. kansasii M. simiae, M. parascrofulaceum, M. kansasii,
M. scrofulaceum, M. gastri, M. fortuitum,
M. conspicuum
M. simiae, M. parascrofulaceum,
M. kansasii, M. scrofulaceum,
M. gastri, M. conspicuum
M. kansasii
240 M. interjectum M. celatum, M. malmoense Mycobacteria sp. M. celatum or 99.07% M.
malmoense-M. simiae
a Sequence identity 100% unless otherwise specified.
b ND, not determined.
c M. parascrofulaceum not included in RIDOM database.
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Isolates must be tested individually. The PCR-RFLP assay
requires traditional gel electrophoresis and manual interpre-
tation and is therefore labor-intensive. Pyrosequencing and
more traditional Sanger sequencing (microsequencing) are
similar assays, although pyrosequencing allows for high-
throughput testing, while multiple samples take much longer
with traditional sequencing. Interpretation of either assay is
performed by comparison to sequence databases, which vary in
quality.
This study confirms the accuracy of a previously described
method, pyrosequencing, for the identification of mycobacte-
rial species (10) and agrees that this method appropriately
identifies 90% of clinical isolates. In the present study, ad-
ditional species were tested, including M. goodii, M. mal-
moense, M. peregrinum, M. szulgai, and clinical isolates of M.
marinum. These additional species were correctly identified.
Pyrosequencing also compared favorably to identification by
HPLC and by classic 16S rRNA sequencing. As noted previ-
ously, use of the forward primer as sequencing primer did not
misidentify M. kansasii or M. scrofulaceum. However, multiple
identifications were possible.
In conclusion, more than 90% of isolates, including M. tu-
berculosis complex as well as nontuberculous mycobacteria
commonly found in the clinical laboratory, were correctly iden-
tified to the complex or species level by pyrosequencing with a
single primer. Since shorter sequences are generated, this
method is not as discriminating as more-traditional sequenc-
ing. As with other sequencing identification techniques, the
principal limitation is the quality of the available databases.
When GenBank is used as a database, some ambiguity on
identification may exist due to the free-access nature of the
data submitted (5, 11). The RIDOM database in particular
censors this information (6). The use of public databases or the
Identifire software (Biotage, Uppsala, Sweden) does allow the
addition of new species. Although no single test methodology
can provide 100% accurate results (9), less than 5% (9 of 206)
of isolates tested were truly discordant between pyrosequenc-
ing and alternative identification methods. Pyrosequencing has
promise as a method for the identification of mycobacteria in
the clinical laboratory. It is reasonably inexpensive but it is a
technique that requires molecular expertise. Due to the ambi-
guity in identifications of a few species, an additional identifi-
cation method will be necessary for specific isolates, perhaps
until alternative sequencing targets are described.
We appreciate the technical help of Jeaninne Huffman, Brian
Vance, and the Tampa General Microbiology Laboratory. The helpful
conversations of Marion Tuohy and Cathy Accurso are also appreci-
ated.
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TABLE 3. Clinical isolates identified by pyrosequencing correlating












M. fortuitum-M. peregrinum M. fortuitum complex 11
M. gordonae I or II M. gordonae 4
M. malmoense M. malmoense 1
M. marinum M. marinum 2
M. nonchromogenicum-M.
terrae or M. terrae-M.
nonchromogenicum
M. terrae 2
M. tuberculosis complex M. tuberculosis complex 5
M. xenopi I or II M. xenopi 1
a MAC, M. avium complex.









Target and sensitivity Overalltime
Pyrosequencinga Variesf 216 10 ng DNA 4.75 h
Microsequencingb Variesf 9 25 ng DNA 6.5 h
HPLCc 25 71 Mycolic acids from
very few cells
2.25 h
DNA probesd 1 —g RNA from a single
colony
50 min
hsp65 RFLPe 25 —g Unspecified quantity
of DNA
6.5 h
a PCR optimization for pyrosequencing, Biotage, Uppsala, Sweden.
b MicroSeq 500 16S rRNA gene bacterial identification kit, Applied Biosys-
tems, Foster City, CA.
c MIDI Sherlock identification system (Newark, DE).
d Accuprobe culture identification test, Gen-Probe Inc., San Diego, CA.
e Telenti et al. (8).
f Varies as database content varies.
g —, 154 for DNA probes, HPLC, and hsp65 RFLP in combination.
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